Free Trial
OTCMKTS:PVCT

Provectus Biopharmaceuticals (PVCT) Stock Price, News & Analysis

Provectus Biopharmaceuticals logo
$0.08 0.00 (-1.43%)
As of 03:41 PM Eastern

About Provectus Biopharmaceuticals Stock (OTCMKTS:PVCT)

Key Stats

Today's Range
$0.07
$0.08
50-Day Range
$0.07
$0.10
52-Week Range
$0.04
$0.15
Volume
56,857 shs
Average Volume
163,208 shs
Market Capitalization
$31.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PVCT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

PVCT Stock News Headlines

Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.
Provectus announces $3M seed financing round for VisiRose
Provectus announces the launch of VisiRose
See More Headlines

PVCT Stock Analysis - Frequently Asked Questions

Provectus Biopharmaceuticals' stock was trading at $0.1201 on January 1st, 2025. Since then, PVCT shares have decreased by 37.1% and is now trading at $0.0756.

Shares of PVCT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Provectus Biopharmaceuticals investors own include Vertex Energy (VTNR), Good Times Restaurants (GTIM), Merck & Co., Inc. (MRK), Oncolytics Biotech (ONC), American Superconductor (AMSC), Cannabis Science (CBIS) and (DARA) (DARA).

Company Calendar

Today
7/09/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:PVCT
Previous Symbol
NYSEMKT:PVCT
CIK
315545
Employees
4
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$4.76 million
Net Margins
-815.81%
Pretax Margin
-823.71%

Debt

Sales & Book Value

Annual Sales
$620 thousand
Price / Cash Flow
N/A
Book Value
($0.01) per share
Price / Book
-7.56

Miscellaneous

Free Float
358,499,000
Market Cap
$31.77 million
Optionable
Not Optionable
Beta
0.75
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (OTCMKTS:PVCT) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners